These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22112485)

  • 41. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
    Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
    Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.].
    Malov SI; Malov IV; Dvornichenko VV; Rasulov RI; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
    Klin Lab Diagn; 2019; 64(10):607-612. PubMed ID: 31742954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies.
    Cai MY; Tong ZT; Zheng F; Liao YJ; Wang Y; Rao HL; Chen YC; Wu QL; Liu YH; Guan XY; Lin MC; Zeng YX; Kung HF; Xie D
    Gut; 2011 Jul; 60(7):967-76. PubMed ID: 21330577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current Practice of Hepatocellular Carcinoma Surveillance.
    Loho IM; Siregar L; Waspodo AS; Hasan I
    Acta Med Indones; 2018 Oct; 50(4):353-360. PubMed ID: 30631003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
    Feng H; Li B; Li Z; Wei Q; Ren L
    BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Magnetic resonance imaging characterization of hepatocellular carcinoma expressing progenitor cell markers.
    Ward SC; Rosen A
    Liver Int; 2012 Mar; 32(3):349-51. PubMed ID: 22309102
    [No Abstract]   [Full Text] [Related]  

  • 47. A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma.
    Luo P; Yin P; Hua R; Tan Y; Li Z; Qiu G; Yin Z; Xie X; Wang X; Chen W; Zhou L; Wang X; Li Y; Chen H; Gao L; Lu X; Wu T; Wang H; Niu J; Xu G
    Hepatology; 2018 Feb; 67(2):662-675. PubMed ID: 28960374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progress and prospects of biomarkers in primary liver cancer (Review).
    Gao YX; Yang TW; Yin JM; Yang PX; Kou BX; Chai MY; Liu XN; Chen DX
    Int J Oncol; 2020 Jul; 57(1):54-66. PubMed ID: 32236573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatocellular carcinoma: important biomarkers and their significance in molecular diagnostics and therapy.
    Sengupta B; Siddiqi SA
    Curr Med Chem; 2012; 19(22):3722-9. PubMed ID: 22680921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HCCR-1 for detecting small hepatocellular carcinoma latent in a cirrhotic liver: a prospective cohort study.
    Jirun P; Zhang G; Ha SA; Kim HK; Yoo J; Kim S; Zhongtian J; Zhuqingqing C; Lee YS; Gong GH; Yoon JH; Lee HN; Kim SJ; Kim TE; Song EY; Lee YK; Park YG; Kim JW
    Gut; 2012 Oct; 61(10):1514-5. PubMed ID: 22851668
    [No Abstract]   [Full Text] [Related]  

  • 52. Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma.
    Wang X; Kwak KJ; Yang Z; Zhang A; Zhang X; Sullivan R; Lin D; Lee RL; Castro C; Ghoshal K; Schmidt C; Lee LJ
    PLoS One; 2018; 13(6):e0198552. PubMed ID: 29879168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular pathogenesis and early detection of hepatocellular carcinoma--perspectives from West Africa.
    Mendy M; Walton R
    Cancer Lett; 2009 Dec; 286(1):44-51. PubMed ID: 19523756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment.
    Piñero F; Dirchwolf M; Pessôa MG
    Cells; 2020 Jun; 9(6):. PubMed ID: 32492896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of Lamin B1, Vimentin and Anti-Ku86 as Prospective Biomarkers of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection.
    Idriss NK; Fakhry M; Imam HM; Abd-Elmoez FA; Abdelewahab H; Abdel-Wahid L; Abbas WA; Abozaid MAA; Sayed Z; Ashmawy AM
    Cell Physiol Biochem; 2019; 52(3):595-605. PubMed ID: 30897324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [How to improve the histopathological diagnosis of hepatocellular carcinoma in daily practice?].
    Honsová E; Lodererová A
    Cesk Patol; 2011 Apr; 47(2):40-3. PubMed ID: 21604432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
    Parizadeh SM; Jafarzadeh-Esfehani R; Ghandehari M; Goldani F; Parizadeh SMR; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Avan A
    Curr Drug Targets; 2019; 20(11):1129-1140. PubMed ID: 30848198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The expression and clinical significance of TPM4 in hepatocellular carcinoma.
    Li L; Ye T; Zhang Q; Li X; Ma L; Yan J
    Int J Med Sci; 2021; 18(1):169-175. PubMed ID: 33390785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Promoting thorough action for early screening, diagnosis and treatment of liver cancer].
    Fan R; Hou JL
    Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):817-821. PubMed ID: 31941233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue and serum metabolomic phenotyping for diagnosis and prognosis of hepatocellular carcinoma.
    Han J; Han ML; Xing H; Li ZL; Yuan DY; Wu H; Zhang H; Wang MD; Li C; Liang L; Song YY; Xu AJ; Wu MC; Shen F; Xie Y; Yang T
    Int J Cancer; 2020 Mar; 146(6):1741-1753. PubMed ID: 31361910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.